Insider Transactions in Q1 2025 at Oncocyte Corp (OCX)
Insider Transaction List (Q1 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 07
2025
|
Andrea S. James Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
97,561
+39.21%
|
$195,122
$2.05 P/Share
|
|
Feb 07
2025
|
Patrick W Smith > 10% Shareholder |
BUY
Other acquisition or disposition
|
Indirect |
385,814
+10.59%
|
$771,628
$2.05 P/Share
|
|
Feb 07
2025
|
Patrick W Smith > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
1,077,600
+27.28%
|
$2,155,200
$2.05 P/Share
|
|
Feb 06
2025
|
Broadwood Partners, L.P. > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
0
|
-
|
|
Feb 06
2025
|
Broadwood Partners, L.P. > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
5,165,695
+18.52%
|
$10,331,390
$2.05 P/Share
|
|
Feb 04
2025
|
Patrick W Smith > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
25
+0.0%
|
$50
$2.02 P/Share
|
|
Jan 31
2025
|
Patrick W Smith > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
890
+0.05%
|
$1,780
$2.01 P/Share
|
|
Jan 30
2025
|
Patrick W Smith > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
318
+0.02%
|
$636
$2.01 P/Share
|
|
Jan 29
2025
|
Patrick W Smith > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
3,880
+0.22%
|
$7,760
$2.01 P/Share
|
|
Jan 14
2025
|
Patrick W Smith > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
10,386
+0.29%
|
$20,772
$2.12 P/Share
|
|
Jan 13
2025
|
Patrick W Smith > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
5,669
+0.32%
|
$11,338
$2.08 P/Share
|